PRELIMINARY PRINT

Volume 598 U. S. Part 1 Pages 115–141

OFFICIAL REPORTS OF

THE SUPREME COURT February 28, 2023

Page Proof Pending Publication

REBECCA A. WOMELDORF reporter of decisions

NOTICE: This preliminary print is subject to formal revision before the bound volume is published. Users are requested to notify the Reporter of Decisions, Supreme Court of the United States, Washington, D.C. 20543, [email protected], of any typographical or other formal errors. OCTOBER TERM, 2022 115

Syllabus

DELAWARE v. PENNSYLVANIA et al.

on exceptions to reports of special master No. 145, Orig. Argued October 3, 2022—Decided February 28, 2023* A State may take custody of abandoned property located within its bor- ders; this process is commonly known as “escheatment.” When aban- doned property is intangible, however, the lack of a physical location means that multiple States may have arguable claims. In these cases, the question is which States have the right to escheat two fnancial products sold by banks on behalf of MoneyGram: Agent Checks and Teller's Checks (collectively, Disputed Instruments). Operating much like money orders, both products are prepaid fnancial instruments used to transfer funds to a named payee. When these prepaid instruments are not presented for payment within a certain period of time, they are deemed abandoned, and, currently, MoneyGram applies the common-law escheatment practices outlined in Texas v. New Jersey, 379 U. S. 674. There the Court established the rule that the proceeds of abandoned fnancial products should escheat to the State of the creditor's last Page Proof Pending Publication known address, id., at 680–681, or where such records are not kept, to the State in which the company holding the funds is incorporated, id., at 682. Because MoneyGram does not, as a matter of regular business practice, keep records of creditor addresses for the two products at issue in these cases, it applies the secondary common-law rule and transmits the abandoned proceeds to its State of incorporation, i. e., Delaware. Multiple States invoked this Court's original jurisdiction to determine whether the abandoned proceeds of the Disputed Instruments are gov- erned by the Disposition of Abandoned Money Orders and Traveler's Checks Act (Federal Disposition Act or FDA) rather than the common law. The FDA provides that “a money order . . . or other similar writ- ten instrument (other than a third party bank check)” should generally escheat to “the State in which such . . . instrument was purchased.” 12 U. S. C. § 2503. This Court consolidated the actions and appointed a Special Master. In his initial report, the Special Master concluded that the Disputed Instruments were covered by the FDA. Following oral argument in this Court, he reassessed that decision and issued a second report, concluding that many of the Disputed Instruments were or could

*Together with No. 146, Orig., Arkansas et al. v. Delaware, also on exceptions to reports of Special Master. 116 DELAWARE v. PENNSYLVANIA

Syllabus

be “third party bank check[s],” which are excluded from the FDA and would generally escheat to Delaware under the circumstances. Held: The Disputed Instruments are suffciently “similar” to a money order to fall within the FDA. Pp. 127–141. (a) The parties disagree whether the Disputed Instruments qualify as “money order[s]” or “other similar written instrument[s] (other than a third party bank check)” under § 2503. Because a fnding that the Disputed Instruments are similar to money orders would be suffcient to bring the Disputed Instruments within § 2503's reach, the Court need not decide whether they actually are money orders. Instead, the Court concludes that the Disputed Instruments are suffciently “similar” to money orders so as to fall within the “other similar written instrument” category of the FDA. Pp. 127–134. (1) The Disputed Instruments share two relevant similarities with money orders. First, they are similar in function and operation. Al- though the FDA does not defne “money order,” a variety of dictionary defnitions contemporaneous with the Act's passage universally defne a “money order” as a prepaid fnancial instrument used to transmit a spec- ifed amount of money to a named payee. And this Court's common- law precedents—the backdrop against which the FDA was enacted— Page Proof Pending Publication are in accord with that defnition. In addition, the features that money orders share with the Disputed Instruments, e. g., the fact that they are prepaid, make them likely to escheat, and thus implicate the FDA in the frst place. Second, due to the recordkeeping practices of the entity issuing and holding on to the prepaid funds, abandoned money orders and the Dis- puted Instruments both escheat inequitably under the Court's common- law rules. The FDA was passed to abrogate this Court's common-law precedents precisely because, for certain instruments like money orders, the entities selling such products often did not keep adequate records of creditor address information as a matter of business practice, which meant that the common law's secondary rule mandating escheatment to the State of incorporation always applied. The FDA prevents this “windfall” to the State of incorporation by instead adopting a place-of- purchase escheatment rule that distributes escheats “as a matter of equity among the several States.” §§ 2501(3), 2503. Because Money- Gram does not keep records of creditor addresses as a matter of busi- ness practice, application of the common law to the Disputed Instru- ments would produce the same inequitable result that the FDA is designed to remedy. Pp. 127–132. (2) Delaware's contrary arguments are unpersuasive. First, the State contends that “money order” refers to a specifc commercial prod- Cite as: 598 U. S. 115 (2023) 117

Syllabus

uct labeled as such on the instrument and sold to low-income individuals in small amounts. Unable to present a dictionary defnition that cabins the term as described, Delaware attempts to highlight the various ways in which the Disputed Instruments differ from money orders. But Del- aware never explains how the differences are relevant to the assessment of similarity for FDA purposes or how such differences undermine the similarities previously outlined above. In an effort to make those proffered differences more relevant, Dela- ware asserts that the FDA was actually concerned with dissuading States from adopting costly recordkeeping requirements that would then be passed on to consumers. Delaware argues that the Disputed Instruments are unlike money orders in that the consumers of the Dis- puted Instruments are typically more capable of absorbing the cost of recordkeeping requirements. The text of the FDA, however, does not support this argument. Finally, Delaware's suggestion that § 2503 be read narrowly to avoid creating surplusage and sweeping in all sorts of unintended fnancial products goes too far. While there is some merit to Delaware's concern about a broad defnition of “money order,” this Court need not actually defne that term, as it suffces under the FDA that the instruments in question be “similar” to a money order. Pp. 132–134. Page Proof Pending Publication (b) Both Delaware and, to some extent, the Special Master, claim that even if the Disputed Instruments qualify as “other similar written in- strument[s]” under the FDA, they are also “third party bank check[s],” which are expressly excluded from the FDA. The problem with this argument is that the FDA does not defne that phrase. Nor does that phrase have a commonly accepted meaning. Delaware insists that the term means a check signed by a bank offcer and paid through a third party. But the State provides no theory as to why it matters to the FDA's escheatment rules whether a fnancial instrument is or is not paid through a third party. In his Second Interim Report, the Special Mas- ter offered the view that “third party bank check” was intended to ex- clude from the FDA's reach certain well-known fnancial instruments upon which a bank may be liable, specifcally, cashier's checks, certifed checks, and teller's checks and thus, to the extent a bank shares liability with MoneyGram on a Disputed Instrument, that product should like- wise be characterized as a third party bank check and thereby excluded from the FDA. The Special Master did not explain why Congress would use an amorphous term to describe well-known fnancial products, while also calling out other well-known instruments, such as money or- ders, by name in the FDA. Nor did the Special Master explain how bank liability relates to the FDA's escheatment rules in any meaningful way. Bank liability also does not seem to be a tipping point for trigger- 118 DELAWARE v. PENNSYLVANIA

Syllabus

ing an exclusion from the FDA given that banks can be liable on money orders and those products are expressly covered by the statute. Fi- nally, the legislative history of the FDA does not support the contention that the Disputed Instruments constitute “third party bank check[s].” The well-documented circumstances surrounding the insertion of the phrase into § 2503 support the conclusion that, whatever the intended meaning of “third party bank check,” it cannot be read broadly to ex- clude from the FDA large swaths of prepaid instruments that escheat inequitably due to the business practices of the company holding the funds. Pp. 135–140. Exceptions to Special Master's First Interim Report overruled; First In- terim Report and order adopted to the extent consistent with this opin- ion; and cases remanded.

Jackson, J., delivered the opinion for a unanimous Court with respect to Parts I, II, III, and IV–A, and the opinion of the Court with respect to Part IV–B, in which Roberts, C. J., and Sotomayor, Kagan, and Kav- anaugh, JJ., joined.

Neal Kumar Katyal argued the cause for Delaware. Page Proof Pending Publication With him on the briefs were Katherine B. Wellington, Jo- Ann Tamila Sagar, Steven S. Rosenthal, Tiffany R. Mose- ley, John David Taliaferro, Marc S. Cohen, and Kathleen Jennings, Attorney General of Delaware, Aaron R. Gol- dstein, State Solicitor, and Michelle E. Whalen and Anthony J. Testa, Jr., Deputy Attorneys General. Nicholas J. Bronni, Solicitor General of Arkansas, argued the cause for Arkansas et al. With him on the brief were Leslie Rutledge, Attorney General of Arkansas, and Vincent M. Wagner, Deputy Solicitor General, Steve Marshall, Attor- ney General of Alabama, Mark Brnovich, Attorney General of Arizona, Rob Bonta, Attorney General of California, Mi- chael J. Mongan, Solicitor General, Jonathan L. Wolff, Chief Assistant Attorney General, Tamar Pachter, Senior Assist- ant Attorney General, Aimee Feinberg, Deputy Solicitor General, Molly K. Mosley, Supervising Deputy Attorney General, and Michael Sapoznikow, Deputy Attorney Gen- eral, Philip J. Weiser, Attorney General of Colorado, Ashley Moody, Attorney General of Florida, Lawrence G. Wasden, Cite as: 598 U. S. 115 (2023) 119

Opinion of the Court

Attorney General of Idaho, Todd Rokita, Attorney General of Indiana, Tom Miller, Attorney General of Iowa, Derek Schmidt, Attorney General of Kansas, Daniel Cameron, At- torney General of Kentucky, Jeff Landry, Attorney General of Louisiana, Brian Frosh, Attorney General of Maryland, Dana Nessel, Attorney General of Michigan, Austin Knud- sen, Attorney General of Montana, Doug Peterson, Attorney General of Nebraska, Aaron D. Ford, Attorney General of Nevada, Wayne Stenehjem, Attorney General of North Da- kota, Dave Yost, Attorney General of Ohio, John M. O'Con- nor, Attorney General of Oklahoma, Ellen F. Rosenblum, At- torney General of Oregon, Alan Wilson, Attorney General of South Carolina, Ken Paxton, Attorney General of Texas, Patrick K. Sweeten, Associate Deputy Attorney General, and Ryan D. Walters, Sean D. Reyes, Attorney General of Utah, Mark Herring, Attorney General of Virginia, Bob Ferguson, Attorney General of Washington, Patrick Morrisey, Attor- ney General of West Virginia, Joshua L. Kaul, Attorney Page Proof Pending Publication General of Wisconsin, and Karla Z. Keckhaver, Assistant At- torney General, Bridget Hill, Attorney General of Wyoming, Matthew H. Haverstick, Mark E. Seiberling, Joshua J. Voss, Lorena E. Ahumada, Christopher B. Craig, and Jennifer Langan.† Justice Jackson delivered the opinion of the Court.* “Escheatment” is the power of a State, as a sovereign, to take custody of property deemed abandoned. Texas v. New Jersey, 379 U. S. 674, 675 (1965). In the context of tangible property, the escheatment rule is straightforward: The State in which the abandoned property is located has the power to take custody of it. Id., at 677. But determining which

†Briefs of amici curiae were fled in both cases for the American Bank- ers Association by Joseph R. Guerra; and for Unclaimed Property Profes- sionals Organization by Sara A. Lima and Ethan D. Millar. *Justice Thomas, Justice Alito, Justice Gorsuch, and Justice Barrett join all but Part IV–B of this opinion. 120 DELAWARE v. PENNSYLVANIA

Opinion of the Court

State has the power to escheat intangible property, which has no physical location, can be complicated, as multiple States may have arguable claims. See ibid. These original jurisdiction cases require us to decide which States have the power to escheat the proceeds of cer- tain abandoned fnancial products that MoneyGram Payment Systems, Inc. (MoneyGram), possesses. Delaware argues that this Court's common-law rules of escheatment apply, which means that the abandoned proceeds should go to Dela- ware as MoneyGram's State of incorporation. A collective of other States (Defendant States) argues that a federal stat- ute—the Disposition of Abandoned Money Orders and Trav- eler's Checks Act (Federal Disposition Act or FDA), 88 Stat. 1525, 12 U. S. C. § 2501 et seq.—governs the products at issue, and therefore, as a general matter, the abandoned proceeds should escheat to the State where the products were pur- chased. We hold that the FDA covers the instruments in question and thus that they should generally escheat to the Page Proof Pending Publication State of purchase, pursuant to § 2503.

I To decide which escheatment rules apply, we must inter- pret a federal statute that abrogates our precedent. Thus, we begin with a discussion of this Court's common-law rules for escheatment, followed by a description of the statute that partially displaced those rules.

A Our frst case to address the escheatment of intangible property involved Western Union money orders. Western Union Telegraph Co. v. Pennsylvania, 368 U. S. 71, 72 (1961). At the time, if an individual wanted to safely send money to another person, she could go to a Western Union offce and purchase a money order. Ibid. Such a purchaser would give Western Union the value of the money order plus a fee. Ibid. Then, Western Union would send a telegraph message Cite as: 598 U. S. 115 (2023) 121

Opinion of the Court

to the company offce closest to the intended recipient (or “intended payee”). Ibid. Upon notifcation, the intended payee could come to his local Western Union offce to collect a negotiable draft, which he could cash immediately or keep to cash in the future. Ibid. Sometimes, however, the prepaid draft was never collected or cashed. Id., at 72–73. At that point, Western Union would endeavor to issue a refund to the purchaser. Ibid. But if neither the purchaser nor the payee ever collected the prepayment, Western Union would hold on to the funds until they were deemed abandoned under state law, at which point the property could become eligible for escheatment. Ibid.; see also Pennsylvania v. New York, 407 U. S. 206, 209 (1972). Texas outlined the rules that this Court established for determining which State has the right to take custody of such abandoned property. 379 U. S., at 680–682. That case involved various small debts held by Sun Oil Company, and multiple States asserted the right to escheat the funds. Id., Page Proof Pending Publication at 675–676. To resolve the competing claims, we estab- lished that, as the primary (default) rule, the proceeds of abandoned fnancial products should escheat “to the State of the creditor's last known address as shown by the debtor's books and records.” Id., at 680–681.1 We further acknowledged that there would be times in which that primary rule would not resolve the escheatment question, either because the creditors' addresses were un- known or because the State that is entitled to escheatment under the primary rule did not have a law empowering it to take custody of the proceeds. Id., at 682. So we also

1 We have previously described the “debtor” as the entity holding the prepaid funds equivalent to the value of the money order, for example, Western Union or MoneyGram, which would be contractually obligated to pay those funds to certain recipients. Delaware v. New York, 507 U. S. 490, 503 (1993). The “creditors” can be both the intended payee and, where the debtor has an obligation to provide a refund if the draft is never paid out, the original purchaser. Ibid. 122 DELAWARE v. PENNSYLVANIA

Opinion of the Court

adopted a secondary rule to apply in those circumstances; namely, that the proceeds should escheat to the debtor's State of incorporation. Ibid. These rules were designed, at least in part, to distribute escheats equitably. We selected escheatment to the State of the creditor's last known address as the default principle because it “tend[ed] to distribute escheats among the States in the proportion of the commercial activities of their resi- dents.” Id., at 681. By contrast, escheatment to the State of incorporation of the debtor (our secondary rule) “would too greatly exhalt a minor factor”—i. e., where the debtor chose to incorporate—when the underlying “obligations [were] incurred all over the country.” Id., at 680. How- ever, we believed the secondary rule was likely to apply “with comparative infrequency.” Id., at 682. It soon became clear that our primary and secondary es- cheatment rules were resulting in inequitable distributions, Page Proof Pending Publication at least with respect to particular instruments, because Western Union largely did not keep records of the addresses of the purchasers or payees of the money orders that the company sold, as a matter of business practice. Pennsylva- nia, 407 U. S., at 211–212, 214. The default rule thus rarely applied in practice, such that proceeds from abandoned West- ern Union money orders largely escheated to New York, Western Union's State of incorporation, pursuant to the sec- ondary rule. Id., at 212, 214. Characterizing this “windfall” as unfair, Pennsylvania fled an action that asked us to reconsider Texas's escheatment rules. 407 U. S., at 213–215. Pennsylvania argued that the proceeds from an abandoned money order should escheat to the State where the money order was purchased rather than the State of the creditor's last known address. Id., at 212, 214. This proposal approximated our primary rule under the commonsense assumption that a money order is usually purchased in the State where the creditor lives, but it obvi- ated the need to require additional recordkeeping by the Cite as: 598 U. S. 115 (2023) 123

Opinion of the Court

debtor. See id., at 214. While we recognized that Pennsyl- vania's proposed escheatment rule had “some surface ap- peal,” we declined to modify the primary and secondary rules established in Texas, noting that States could solve the problem of inequitable escheatment by requiring Western Union to keep suffcient records. 407 U. S., at 214–215.

B Congress passed the FDA two years after our decision in Pennsylvania to abrogate this Court's common-law escheat- ment practices and adopt a more equitable rule, at least for some products. 12 U. S. C. § 2501; Delaware v. New York, 507 U. S. 490, 510 (1993); S. Rep. No. 93–505, pp. 1–3 (1973). In the text of the statute, Congress declared that, “as a matter of equity among the several States,” the States “wherein the purchasers of money orders and traveler's checks reside should . . . be entitled to the proceeds of such Page Proof Pending Publication instruments in the event of abandonment.” § 2501(3). Yet, the statute further recognized that such an equitable distri- bution was not happening under the common-law rules, to the detriment of interstate commerce, because “the books and records of banking and fnancial organizations and busi- ness associations engaged in issuing and selling money or- ders and traveler's checks do not, as a matter of business practice, show the last known addresses of purchasers of such instruments.” § 2501(1); see § 2501(4). Notably, instead of keeping our Texas default rule and mandating recordkeeping requirements for debtors, as we had suggested in Pennsylvania, the FDA addressed the in- equitable escheatment problem by establishing a different set of escheatment rules that displaces this Court's primary and secondary escheatment rules whenever applicable. See § 2503. It states that “[w]here any sum is payable on a money order, traveler's check, or other similar written in- strument (other than a third party bank check) on which a banking or fnancial organization or a business association is 124 DELAWARE v. PENNSYLVANIA

Opinion of the Court

directly liable,” the primary escheatment rule is the place- of-purchase rule that Pennsylvania had proposed in the Pennsylvania case. § 2503(1). Thus, per the FDA, the proceeds of the listed fnancial in- struments escheat to the State of purchase upon abandon- ment, so long as purchase-location information is known and that State has enacted laws empowering it to take custody of those proceeds. Ibid.2 The text of the FDA also ex- plains why the inequitable escheatment problem was handled in this fashion rather than by adopting a recordkeeping re- quirement for debtors holding on to abandoned funds. See § 2501(5) (observing that “the cost of maintaining and re- trieving addresses of purchasers of money orders and travel- er's checks is an additional burden on interstate commerce” that is unnecessary “since it has been determined that most purchasers reside in the State of purchase of such instruments”). II Page Proof Pending PublicationA Although the telegraphic aspect of Western Union's money order business has fallen into disuse, money orders are still 2 In full, the primary escheatment rule of the FDA states: “Where any sum is payable on a money order, traveler's check, or other similar written instrument (other than a third party bank check) on which a banking or fnancial organization or a business association is directly liable– “(1) if the books and records of such banking or fnancial organization or business association show the State in which such money order, travel- er's check, or similar written instrument was purchased, that State shall be entitled exclusively to escheat or take custody of the sum payable on such instrument, to the extent of that State's power under its own laws to escheat or take custody of such sum.” § 2503. Subsections (2) and (3) adopt alternative rules that apply when there is insuffcient information about where the instrument was purchased, and/ or when the State of purchase does not have laws permitting the escheat- ment of such property. In those circumstances, the abandoned proceeds from covered instruments escheat to the State where the company holding the funds has its principal place of business. §§ 2503(2)–(3). Cite as: 598 U. S. 115 (2023) 125

Opinion of the Court

sold today for the same purpose: to safely transmit funds to an intended payee.3 Many banks have outsourced the issu- ance and handling of these kinds of prepaid fnancial instru- ments to businesses such as MoneyGram. The parties have identifed four MoneyGram products as relevant to this litigation. MoneyGram calls these fnancial instruments “Retail Money Orders,” “Agent Check Money Orders,” “Agent Checks,” and “Teller's Checks.” All of these instruments are products that MoneyGram creates and markets but that are sold to customers by another entity (either a retail location or bank) on behalf of MoneyGram. As a general matter, these four MoneyGram products op- erate in the same manner. The purchaser prepays the face value of the instrument, plus any fee, and MoneyGram holds the proceeds (which have been sent to them by the seller entity) until the intended payee presents the instrument for payment. In addition, as a matter of business practice, MoneyGram keeps only limited records about transactions Page Proof Pending Publication concerning these products. The seller entity transmits in- formation to MoneyGram that identifes where the product was sold, among other things, but the seller does not include in the information given to MoneyGram the identity or ad- dress of the purchaser or payee (even if the seller collects that information). The heart of the instant dispute relates to how Money- Gram handles the abandoned proceeds of these products. MoneyGram considers two of the four products—Retail Money Orders and Agent Check Money Orders—as falling within the scope of the FDA, so it gives the abandoned pro- ceeds of those particular instruments to the States of pur- chase in accordance with § 2503. But MoneyGram treats

3 In addition to being a safe alternative to cash for transmitting money, money orders and similar prepaid instruments have an advantage over standard checks in that, because they are prepaid, they do not depend on the purchaser having suffcient funds in her bank account (in ordinary parlance, they cannot “bounce”). 126 DELAWARE v. PENNSYLVANIA

Opinion of the Court

Agent Checks and Teller's Checks (collectively, the Disputed Instruments) as governed by the common law instead of the FDA. Because MoneyGram does not keep records of credi- tor addresses for these products, MoneyGram applies the secondary rule of Texas and gives the abandoned proceeds of those particular instruments to its State of incorpora- tion, Delaware. B After an audit of MoneyGram's escheatment policies, Pennsylvania and Wisconsin fled separate lawsuits challeng- ing Delaware's escheatment of the abandoned proceeds of Agent Checks and Teller's Checks. Invoking this Court's original jurisdiction to decide controversies between States, Delaware moved to fle a bill of complaint against Pennsylva- nia and Wisconsin. Arkansas, acting on behalf of itself and several other States, fled a separate motion for leave to fle a bill of complaint. We consolidated the actions and ap- Page Proof Pending Publication pointed a Special Master. The Special Master bifurcated the proceedings into liabil- ity and damages phases. The frst phase (to which the cur- rent dispute pertains) focuses solely on which State or States have priority to take custody of the proceeds from Money- Gram Agent Checks and Teller's Checks upon abandonment. At the second phase, the Special Master will analyze any damages. The parties filed cross-motions for summary judgment on the issue of liability. In July 2021, the Special Master issued a First Interim Report that concluded that the Disputed Instruments were covered by the FDA. Delaware fled exceptions to that re- port. Then, after we had considered the parties' briefs and held oral argument, the Special Master announced that our proceedings had caused him to reassess his conclusions. He subsequently issued a Second Interim Report that concluded that many of the Disputed Instruments were or could be “third party bank checks” and would thereby be excluded from the FDA, which means that, when abandoned, they Cite as: 598 U. S. 115 (2023) 127

Opinion of the Court

would generally escheat to Delaware under the common law. Both parties submitted exceptions to the Special Master's Second Interim Report. III The parties are at odds over whether the Disputed Instru- ments qualify as “money order[s]” or “other similar written instrument[s] (other than a third party bank check)” within the meaning of the FDA, § 2503—a determination that, for present purposes, establishes whether the FDA or the com- mon law governs their escheatment when abandoned. We conclude that the Disputed Instruments are covered by the FDA because they are “other similar written instrument[s],” and neither Delaware nor the Special Master has convinced us that they are “third party bank check[s].” Ibid.

A Because the plain text of the FDA applies to not only Page Proof Pending Publication money orders and traveler's checks but also written instru- ments that are “similar” to those fnancial products, ibid., we need not determine whether the Disputed Instruments are money orders; a fnding that they are similar to money or- ders is suffcient to bring them within the reach of the stat- ute (so long as they are not third party bank checks).4 We determine what “similar” entails in light of the FDA's “text and context,” Southwest Airlines Co. v. Saxon, 596 U. S. –––, ––– (2022), not in the abstract. And in these particular cases, the Disputed Instruments share two relevant similari- ties with money orders. Those instruments operate in the same manner as money orders do (as defned by contempora- 4 The parties agree that the Disputed Instruments are not traveler's checks, which are a type of prepaid fnancial product characterized by a double signature: the purchaser signs once when purchasing the instru- ment and then again when redeeming it. Accordingly, although traveler's checks share the characteristics outlined infra, at 128–131, for simplicity's sake, we focus on the similarities between money orders and the Disputed Instruments, in the context of § 2503, for purposes of this opinion. 128 DELAWARE v. PENNSYLVANIA

Opinion of the Court

neous dictionaries and our prior escheatment cases), and they also implicate the one feature of money orders that the text of the FDA explicitly identifes, insofar as the Disputed Instruments escheat inequitably solely to one State under our common-law rules due to the business practices of the company holding the funds. First, the Disputed Instruments are similar to money or- ders in function and operation. The FDA does not defne a “money order,” so the core features of that instrument are gleaned from a consideration of the “ `ordinary, contempo- rary, common meaning' ” of the term. Sandifer v. United States Steel Corp., 571 U. S. 220, 227 (2014) (quoting Perrin v. United States, 444 U. S. 37, 42 (1979)). The parties cite a variety of contemporaneous dictionary defnitions and ency- clopedia descriptions for the term, and, at the most basic level, a money order is universally defned as a prepaid (or “purchased”) fnancial instrument used to transmit money to Page Proof Pending Publication a named payee.5 Some of the dictionaries further indicate that a money order involves a “specifed sum of money.” Webster's Seventh New Collegiate Dictionary 547 (1972); see also American Heritage Dictionary 847 (1969) (“a specifed amount of money”). These features—i. e., prepayment of a specifed amount of money to be transmitted to a named payee—generally accord with how we described the Western Union money orders at issue in our prior escheatment cases. See Pennsylvania, 407 U. S., at 208; Western Union Telegraph Co., 368 U. S., at 72. And the FDA was enacted against the backdrop of the

5 See, e. g., Black's Law Dictionary 907 (5th ed. 1979); Glenn G. Munn's Encyclopedia of Banking and Finance 581 (rev. 7th ed. 1973); Webster's Seventh New Collegiate Dictionary 547 (1972); 15 Compton's Encyclopedia and Fact-Index 430 (1970); American Heritage Dictionary 847 (1969); Black's Law Dictionary 1158 (rev. 4th ed. 1968). While these sources do not use the term “prepaid,” they describe a prepaid fnancial instrument because they defne a money order as an instrument “purchased” by one party in order to transmit money to another party. Cite as: 598 U. S. 115 (2023) 129

Opinion of the Court

common law as set forth in those cases; indeed, it abrogates the common-law escheatment rules that we adopted in those cases. The statute is naturally read to refect the same basic conception of the term “money order” that we ad- dressed in those precedents. The operation of the FDA further confrms the relevance of the prepayment feature of a money order for the purpose of assessing the similarity of the Disputed Instruments. The FDA plainly regulates the escheatment of abandoned fnancial products, and when fnancial instruments are pre- paid, the likelihood of their abandonment (and thus the po- tential for escheatment) increases, as the holder of the pro- ceeds of such instruments has possession of the prepaid sums of money if the instruments are never collected or presented for payment. See Pennsylvania, 407 U. S., at 208. Thus, the FDA naturally applies to prepaid instruments, such as money orders, given that those instruments are of a type Page Proof Pending Publication likely to implicate the FDA's escheatment rules. And Dela- ware does not dispute that, just like money orders, the Dis- puted Instruments are prepaid written fnancial instruments used to transmit money to intended payees. Second, the Disputed Instruments are similar to the “money orders” that the FDA targets because they inequita- bly escheat in the manner that the text of the FDA specif- cally identifes as warranting statutory intervention. Just as with the money orders in Pennsylvania, the company holding the proceeds of the Disputed Instruments (Money- Gram) does not keep adequate records of creditor addresses as a matter of business practice. And the FDA abrogates this Court's escheatment precedents on this very basis. See §§ 2501, 2503. Consequently, the inherent characteristics of money orders are not the only relevant point of similarity between money orders and the Disputed Instruments; in ad- dition, they both would otherwise escheat inequitably under the secondary common-law rule due to the business practices of the company holding the funds. 130 DELAWARE v. PENNSYLVANIA

Opinion of the Court

The context in which the FDA arises underscores the meaningfulness of this similarity. Our common-law rules were permitting inequitable escheatment (insofar as our pri- mary rule mistakenly relied on the assumption that the hold- ers of such instruments regularly collected creditors' address information), and the statute that Congress enacted in the wake of our Pennsylvania ruling details the inequitable escheatment problem. Thus, the FDA regulates “money orders” (however that term is ordinarily defned) not just for the sake of regulating those particular fnancial in- struments, but because inequitable escheatment occurs under our common-law rules if fnancial instruments do not have address information that can facilitate distribution to the State of entitlement when they are abandoned, and the entities issuing and selling money orders often do not keep adequate records. The lack of related creditor address in- formation was a key feature of the money orders that we Page Proof Pending Publication evaluated when we were asked to revisit our common-law escheatment rules in Pennsylvania, 407 U. S., at 214. So it should come as no surprise that it is likewise a key feature of the statute that Congress enacted to displace our common- law rules. The inadequate-recordkeeping feature of money orders is also derived from the text of the FDA itself. The statute references both our observation in Texas that, “as a matter of equity,” the proceeds of abandoned intangible property should be spread “among the several States,” § 2501(3), and Pennsylvania's subsequent recognition that “the proceeds of such instruments are not being distributed to the States entitled thereto,” § 2501(4). The FDA explains that this in- equity was occurring because “the books and records of banking and fnancial organizations and business associations engaged in issuing and selling money orders and traveler's checks do not, as a matter of business practice, show the last known addresses of purchasers of such instruments.” Cite as: 598 U. S. 115 (2023) 131

Opinion of the Court

§ 2501(1). The operative provision of the statute (§ 2503) then adopts the precise alternative rule of escheatment that Pennsylvania suggested in the face of inequitable escheat- ment caused by a company's business practices. In short, the FDA's text provides a solution for the prob- lem of the inequitable distribution of escheats, and that solu- tion expressly eschews requiring entities like Western Union to keep adequate records. See §§ 2501(5), 2503. Inade- quate recordkeeping is thus highly relevant to the interpre- tive question of when the FDA, rather than the common law, should apply to the escheatment of the intangible property at issue.6 It is uncontested that the Disputed Instruments share the inadequate recordkeeping feature of money orders that the FDA identifes. See § 2501(1). Therefore, if the common law were to apply to the Disputed Instruments, then the abandoned proceeds would escheat inequitably solely to the Page 6 Proof Pending Publication To be sure, the parties and the Special Master conceive of the interpre- tive question before us as how to defne the statutory term “money order,” or whether the Disputed Instruments look enough like a money order to fall within the statute. That is, indeed, one way to view the task at hand. But the text and history of the FDA also suggest an alternative framing. Against the backdrop of the operation of our common-law rules and in light of Congress's effort to abrogate them, the interpretive question be- comes when should the FDA, rather than the common law, apply to partic- ular abandoned intangible property (here, the Disputed Instruments). And the statute's text suggests at least a partial answer: when “the books and records of banking and fnancial organizations and business associa- tions engaged in issuing and selling” the instruments at issue “do not, as a matter of business practice, show the last known addresses of purchasers of such instruments,” such that, absent application of the FDA, the prod- ucts would not be distributed “as a matter of equity among the several States.” §§ 2501(1), (3), (4). This answer follows not only from the FDA's codifed fndings, but also from § 2503, insofar as the text applies both to instruments that can be defned as “money orders” (in light of their inher- ent features) and also to instruments that are “similar” to money orders for escheatment purposes. 132 DELAWARE v. PENNSYLVANIA

Opinion of the Court

State of incorporation, just like the money orders expressly referenced in the statute.7 B Delaware's various arguments as to why the Disputed In- struments should not qualify as “other similar written in- strument[s]” within the meaning of § 2503 are unpersuasive. First up in Delaware's attempt to distinguish the Disputed Instruments from money orders for FDA purposes is its con- tention that the term “money order” in the FDA refers to a specifc commercial product that is labeled “money order” by the seller and is generally sold in low values to low-income individuals as a substitute for ordinary personal checks. Delaware does not point to any dictionary that includes those additional attributes in its defnition of “money order,” nor do any of our prior cases that describe Western Union money orders mention such features. See Pennsylvania, 407 U. S., at 208–209; Western Union Telegraph Co., 368 U. S., at 72– Page Proof Pending Publication 73. Moreover, while Delaware offers two encyclopedia en- tries that suggest money orders are “especially helpful to persons who do not have checking accounts,” 8 neither source says that the typical or intended user is, itself, an attribute of a money order. Delaware also tries to highlight various ways in which the Disputed Instruments can be said to differ from money or- ders, as Delaware describes them, including differences with respect to face values and customer use. But Delaware never explains why those purported differences are relevant to our assessment of similarity for FDA purposes. Since

7 Indeed, the facts of these very cases refect the inequitable escheat- ment dynamic that is at the heart of the FDA: According to the Defendant States, Delaware took $250 million between 2002 and 2017 pursuant to the common law's escheatment rules with respect to Disputed Instruments that were purchased across the Nation, whereas, if the FDA applied, that State would have been entitled to only about $1 million. 8 15 Compton's Encyclopedia and Fact-Index, at 430; see also Glenn G. Munn's Encyclopedia of Banking and Finance, at 581. Cite as: 598 U. S. 115 (2023) 133

Opinion of the Court

money orders and the Disputed Instruments are compara- tors that are not identical, they are likely to be different in some respect. The real question is which differences and similarities matter. And none of the differences Delaware identifes relates to the statutory text or ordinary meaning of a money order, nor do they otherwise undermine the anal- ysis of similarity we outlined above. Undaunted, Delaware attempts to make the differences it identifes seem more material by proffering an alternative vision of the FDA. In this regard, Delaware asserts that the FDA was really an effort to dissuade States from adopt- ing costly recordkeeping requirements, the costs of which might then be passed along to low-income consumers. Its argument is that, because the Disputed Instruments are, when compared to money orders, generally larger value in- struments that are typically purchased by consumers who can more easily absorb any additional recordkeeping-related Page Proof Pending Publication costs, those products simply do not implicate the FDA's core (cost-related) concerns and are thus not “similar” to money orders. But the text of the FDA bears no relationship to Dela- ware's cost argument. Indeed, the statute says absolutely nothing about the rising costs of money orders for low- income individuals. See § 2501. “[T]he cost of maintaining and retrieving addresses of purchasers of money orders and traveler's checks” is only mentioned to explain why a manda- tory recordkeeping option (which we had suggested in Penn- sylvania, 407 U. S., at 215) was not selected as the statutory solution to the inequitable escheatment problem that the FDA plainly addresses. § 2501(5). Nor does it matter that there would be no inequitable es- cheatment with respect to the Disputed Instruments if MoneyGram did not factor into the equation, as Delaware maintains. In this regard, Delaware argues that the Dis- puted Instruments do not implicate the concerns underlying the FDA because the banks that sell the Disputed Instru- 134 DELAWARE v. PENNSYLVANIA

Opinion of the Court

ments generally do keep adequate records, and therefore States can avoid the escheatment problem by passing laws requiring those banks to transmit their records to Money- Gram and requiring MoneyGram to keep those records. But the FDA regulates escheatment, so it is the recordkeeping practices of the entity holding the funds that is relevant. Here, that entity is MoneyGram, not the banks. Money- Gram has the recordkeeping practices identifed as warrant- ing intervention through the FDA, see § 2501(1), and the statute contains a solution to the escheatment problem that MoneyGram's ordinary business practices cause, see § 2503. Finally, Delaware suggests that § 2503 must be read nar- rowly in order to avoid both creating surplusage and sweep- ing in all sorts of fnancial products that Congress did not intend to cover. This goes too far. Although Delaware ar- gues, with some merit, that broadly defning a “money order” as a prepaid instrument used to transmit money to a named payee would render the statute's separate references Page Proof Pending Publication to “traveler's checks” and “other similar written instru- ments” superfuous, we need not defne “money order” in order to conclude that the FDA applies to the Disputed In- struments, since it suffces that the instruments in question be “similar” to a money order; they need not share its defni- tion. And if “other similar written instrument” is inter- preted with reference to both the inherent qualities of a money order and also the recordkeeping concern that the FDA expressly identifes in the text, as discussed above, then the scope of the statute is properly cabined.9 9 It is true that, so interpreted, the status of a particular category of instrument as falling within or outside of the FDA's scope could shift if the company in possession of the funds changes its regular or ordinary business practices. But, given this unusual statute, that is not an anoma- lous outcome. Both Congress (in the text of the FDA) and this Court (in our precedents) have indicated a preference for the equitable distribution of escheats, and our common-law rules can result in equitable escheatment if the business practices of the company possessing the funds suffce. The FDA is a recognition that, sometimes, our common-law rules do not Cite as: 598 U. S. 115 (2023) 135

Opinion of the Court

IV Delaware argues that even if the Disputed Instruments qualify as “other similar written instrument[s]” within the meaning of § 2503 they are also “third party bank check[s]” and, as such, are expressly excluded from the FDA.10 The Special Master, too, ultimately adopted a ver- sion of this argument; in his view, the “third party bank check” exemption applies to any Disputed Instrument on which a bank is liable (in addition to MoneyGram).11 Nei- ther Delaware nor the Special Master has provided a per- suasive reason for concluding that the Disputed Instru- ments are “third party bank check[s]” within the meaning of the FDA, and the drafting history of the statute further confrms that the sweep of that language is not as broad as the defnitions that Delaware and the Special Master have offered. Therefore, as explained below, we do not accept the contention that the Disputed Instruments are Page Proof Pending Publication achieve that outcome, i. e., it is the equivalent of a statutory “Band-Aid” if our common-law rules fail. In other words, the FDA is a statutory fx that need only kick in when, as a matter of business practice, the company holding the funds does not generally collect the relevant address informa- tion, such that inequitable escheatment occurs. The text and context of the FDA—and especially the phrase “other similar written instrument”— connote that fexibility and do not suggest that the statute only and exclu- sively applies to a static category of products. 10 The Special Master concluded that the “third party bank check” ex- emption modifes only “other similar written instrument” and does not modify the terms “money order” or “traveler's check.” Delaware does not challenge this conclusion. 11 When they appeared before the Special Master, the parties and ex- perts disagreed on the meaning of “liability,” and no one has proffered an agreed-upon defnition to this Court. Before us, Delaware does not dis- pute the Special Master's conclusion that MoneyGram is “directly liable” on the Disputed Instruments. When referencing a bank's liability on a MoneyGram product, it appears that the Special Master was using the term to describe a situation where a bank—as opposed to only Money- Gram—also has an obligation to pay the prepaid instrument upon proper presentment. 136 DELAWARE v. PENNSYLVANIA

Opinion of the Court

carved out of the statute per the “third party bank check” language. A First, however, a caveat: We readily admit that discerning the meaning of “third party bank check” in § 2503 is tricky, because the FDA does not defne that phrase, and, as far as we can tell, it does not have an “ordinary, contemporary, com- mon meaning.” Sandifer, 571 U. S., at 227. The parties have not pointed to any contemporary legal or fnancial source that defnes that precise term. And the FDA's “third party bank check” language confounded all three experts re- tained in these cases, each of whom agreed that it has no traditional meaning in either the legal or the fnancial realms. Notably, the Special Master valiantly attempted to bring clarity to this term, adopting three different defni- tions of “third party bank check” over the course of this liti- gation. Ultimately, between the parties and the Special Page Proof Pending Publication Master, we have been offered at least six disparate defni- tions of the term.12 In the midst of this uncertainty, Delaware insists that the term “third party bank check” means a check signed by a bank offcer and paid through a third party. Not surpris- ingly, that defnition fts the Disputed Instruments like a glove, given that they are signed by bank employees and then ultimately paid through MoneyGram, a nonbank third party, when presented. But Delaware provides no support whatsoever for the conclusion that this is what “third party bank check” means in the FDA context. And, indeed, Dela- ware's own expert disagreed with that defnition for FDA purposes. Delaware also has no theory as to why it matters 12 Those defnitions are: an ordinary (nonprepaid) check; a check sold at a bank and paid through a third party such as MoneyGram; a check issued at a bank indorsed to a third party; a check on which a bank is liable that was issued at the instance of a third party; a check on which a bank is liable regardless of whether a third party is involved; a check which is drawn on (and only drawn on) bank accounts. Cite as: 598 U. S. 115 (2023) 137

Opinion of the Court

to the escheatment rules that the statute adopts whether a fnancial instrument is or is not paid through a third party like MoneyGram. Thus, we are hard pressed to agree that “third party bank check” means what Delaware says. The Special Master's analysis fares no better. In his Sec- ond Interim Report, the Special Master offered a potential defnition of “third party bank check” that relies on the view that the phrase was intended to exclude from the FDA's reach certain fnancial instruments that were well known at the time of the statute's enactment but were not expressly mentioned in the statute—specifcally, cashier's checks, certi- fed checks, and teller's checks. According to the Special Master, a signifcant feature of those particular fnancial in- struments at the time of the FDA's enactment was that a bank was liable on those instruments. Therefore, according to the Special Master, insofar as a bank is directly liable on some of the Disputed Instruments (in addition to Money- Gram), any such MoneyGram product is a “bank check” that Page Proof Pending Publication should be deemed to fall within the “third party bank check” exception for purposes of the FDA. We detect multiple problems with the Special Master's reasoning. For one, the Special Master did not explain why the statute uses the amorphous phrase “third party bank check” to capture specifc fnancial instruments that, according to the Special Master, were well known at the time of the enactment of the statute. Congress called out other well-known instruments—money orders and traveler's checks—by their names in the text of the FDA. One would reasonably expect it to have done the same for cashier's checks, certifed checks, and teller's checks.13 The Special Master also failed to provide an adequate ex- planation for why bank liability relates in any meaningful way to the escheatment rules that the FDA adopts. That 13 We are not opining today as to whether the FDA applies to cashier's checks, certifed checks, or non-MoneyGram teller's checks because the dispute before us does not concern those products. 138 DELAWARE v. PENNSYLVANIA

Opinion of the Court

explanation seems crucial because the parties appear to agree that banks can be liable on money orders themselves, and, as previously explained, far from being excluded, money orders are expressly covered items in this statute. This in- congruity makes it hard to conceive of the bank-liability at- tribute as the tipping point for whether a fnancial instru- ment qualifes as a “third party bank check” for FDA purposes. Similarly, if we were to agree with the Special Master that bank liability is dispositive of a “third party bank check” designation, then presumably any draft on which a bank is liable would fall outside of the FDA—a result that reads the term “third party” out of the statute. The Special Master's reasoning further fails to account for the nature of the Disputed Instruments, which do not appear to qualify as “bank checks,” at least not in the traditional sense of that word. According to the parties, a “bank check” is a check “drawn” on a bank's own account or by a bank and on a bank (either the same bank or another).14 Page Proof Pending Publication That does not describe the Disputed Instruments, which are drawn on MoneyGram's account, not a bank's account. Consequently, nothing in the reasoning provided by Dela- ware or the Special Master persuades us that the Disputed Instruments, which are otherwise “similar” to money orders for FDA purposes, should be deemed “third party bank checks” within the meaning of § 2503.

B Nor does the legislative history support Delaware's con- tention that the Disputed Instruments constitute “third party bank checks.” “Those of us who make use of legisla- tive history believe that clear evidence of congressional in- 14 See L. Lawrence, Making Cashier's Checks and Other Bank Checks Cost-Effective: A Plea for Revision of Articles 3 and 4 of the Uniform Commercial Code, 64 Minn. L. Rev. 275, 278 (1980); G. Wallach, Negotiable Instruments: The Bank Customer's Ability To Prevent Payment on Vari- ous Forms of Checks, 11 Ind. L. Rev. 579, 584 (1978). Cite as: 598 U. S. 115 (2023) 139

Opinion of the Court

tent may illuminate ambiguous text.” Milner v. Depart- ment of Navy, 562 U. S. 562, 572 (2011). In the instant situation, while the meaning of the phrase “third party bank check” is subject to myriad alternative defnitions and is gen- erally unknown, the phrase was inserted into § 2503 under well-documented circumstances. And those circumstances further support the conclusion that, whatever “third party bank check” is meant to mean, the Disputed Instruments are not exempted from the FDA under that provision, as Delaware maintains. Specifcally, during the time in which Congress was mull- ing a draft of the FDA's provisions, it solicited the views of the Treasury Department, and the agency's general counsel responded. He wrote a letter stating that, although he did not object to the adoption of the bill's escheatment rules, he “believe[d] the language of the bill [was] broader than in- tended by the drafters.” S. Rep. No. 93–505, at 5 (Letter Page Proof Pending Publication from E. Schmults). According to the letter, agency counsel was concerned, in particular, that the phrase “ `money order, traveler's check, or similar written instrument on which a bank or fnancial organization or business association is di- rectly liable' ” could be interpreted to cover “ `third party payment bank checks.' ” Ibid. Thus, he recommended ex- cluding “third party payment bank checks” from the FDA, ibid., and Congress subsequently adopted this recommenda- tion, dropping the suggested word “payment” in the process, id., at 6; see also § 2503. Reliable sources indicate that the “third party bank check” language was not supposed to be a signifcant addition. The Senate Report described it as a mere “technical” alteration. Id., at 6; see also 120 Cong. Rec. 4528 (1974) (statement of Comm. Chairman Sen. Sparkman referring to the insertion of the language as a “minor” change). Thus, that statutory phrase is reasonably viewed as merely clarifying the in- tended initial scope of coverage (i. e., as an effort to better demarcate the boundaries of a statute that regulates es- 140 DELAWARE v. PENNSYLVANIA

Opinion of the Court

cheatment of “money order[s], traveler's check[s], [and] other similar written instrument[s],” § 2503), rather than as an ex- press exemption that accepts that items of this nature would otherwise qualify for regulation under the terms of the stat- ute and specifcally undertakes to carve them out. In any event, given the history and text of the FDA, it would be strange to interpret the “third party bank check” language to exempt from the statute entire swaths of pre- paid fnancial instruments that are otherwise similar to money orders in that they operate in generally the same fashion and would likewise escheat inequitably pursuant to the common law due to the business practices of the company holding the funds. At the very least, reading the exemption that broadly would imbue “third party bank check” with a meaning that far surpasses a “technical” change. And it would also risk rendering largely ineffectual the FDA's framework for displacement of the common law, as necessary, to ensure equitable escheatment. Page Proof Pending Publication * * * When a fnancial product operates like a money order— i. e., when it is a prepaid written instrument used to transmit money to a named payee—and when it would also escheat inequitably solely to the State of incorporation of the com- pany holding the funds under our common-law rules due to recordkeeping gaps, then it is suffciently “similar” to a money order to fall presumptively within the FDA. Such is the case with the Disputed Instruments. And nothing in the parties' arguments, the Special Master's Second Interim Report, or the record in these cases persuades us that the Disputed Instruments should be deemed “third party bank checks.” Accordingly, we adopt the Special Master's recommenda- tions in the First Interim Report, along with his initial pro- posed order, to the extent they are consistent with this opin- Cite as: 598 U. S. 115 (2023) 141

Opinion of the Court

ion.15 We also overrule Delaware's exceptions to the First Interim Report and remand this matter to the Special Mas- ter for further proceedings consistent with this opinion.16 It is so ordered.

Page Proof Pending Publication

15 Because we decline to adopt the Special Master's Second Interim Re- port, we need not address the Defendant States' argument that we should not entertain the Second Interim Report. 16 In light of our conclusions in these cases, Pennsylvania's alternative request that we reconsider the common-law escheatment rules is moot. Reporter’s Note

The attached opinion has been revised to refect the usual publication and citation style of the United States Reports. The revised pagination makes available the offcial United States Reports citation in advance of publication. The syllabus has been prepared by the Reporter of Decisions Page Proof Pending Publication for the convenience of the reader and constitutes no part of the opinion of the Court. A list of counsel who argued or fled briefs in this case, and who were members of the bar of this Court at the time this case was argued, has been inserted following the syllabus. Other revisions may include adjustments to formatting, captions, citation form, and any errant punctuation. The following additional edits were made:

p. 115, line 19, “this case” is changed to “these cases”